NIKA PHARMACEUTICALS, INC
corporate_fare Company Profile
NIKA PHARMACEUTICALS, INC (OTC:NIKA) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 4 items for NIKA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-10, rated 9/10. Across its 4 most recent items scored 7 or higher, the top rating is 9/10, with 3 rated 8 or above. Recent SEC coverage for NIKA spans 10-Q, 10-K.
Recent high-impact activity:
- Nika Pharmaceuticals Discloses $2,932 in Cash, Reiterates Going Concern Warning, and Flags Ineffective Controls
- Nika Pharmaceuticals Reports Critical Cash Shortage, Going Concern, and Reverses Factory Acquisition
- Annual Report Reveals Going Concern, Ineffective Controls, and Auditor Instability
- Nika Pharmaceuticals Taps MD Global Partners for Strategic Growth, Capital Advisory
Financial Snapshot
Short Interest & Short Volume
FINRA reported short interest of 70 shares in NIKA as of the September 15, 2026 settlement, unchanged from the prior period.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.